Quantcast

Latest Corinne Goldsmith Dickinson Center for Multiple Sclerosis Stories

2014-09-08 08:29:26

--Phase 2a Trial is First to Use Crowdsourcing for Protocol Design and Telemonitoring for Patient Data Collection-- NEW YORK, Sept. 8, 2014 /PRNewswire/ -- Transparency Life Sciences, LLC (TLS), the world's first clinical-stage drug development company based on open innovation, today announced that it has received a Small Business Innovation Research (SBIR) program grant to fund a Phase 2a proof-of-concept study testing the utility of the ACE inhibitor lisinopril as an adjunctive...

2014-07-31 08:34:53

-- Oral Presentation to Include Greater Detail on Clinical Outcomes, Including Significant and Unique Improvements in Cognition -- ROCKVILLE, Md., July 31, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that Rhonda Voskuhl, M.D., the lead investigator of the Phase II clinical trial evaluating...

2014-03-27 08:33:54

What do dietary salt, adult stem cells and gut bacteria have in common? They are among the new leads being explored to move us closer to a world free of MS NEW YORK, March 27, 2014 /PRNewswire-USNewswire/ -- The National Multiple Sclerosis Society has committed another $29 million to support an expected 83 new MS research projects and training awards. These are part of a comprehensive research strategy aimed at stopping MS, restoring function that has been lost, and ending the...

2014-02-27 08:29:29

Site Helps Connect More Than One Million People Each Month To Information, Resources And Support To Live Their Best Lives NEW YORK, Feb. 27, 2014 /PRNewswire-USNewswire/ -- The National Multiple Sclerosis Society has re-designed its website to help people affected by MS better and more easily connect to the information, resources and support that can help them live their best lives. http://photos.prnewswire.com/prnvar/20090302/DC77093LOGO Visit www.nationalMSsociety.org to experience:...

2014-02-10 08:25:28

ROCKVILLE, Md., Feb. 10, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of product candidates focused on the prevention and treatment of serious infectious and other diseases, announced today that Rhonda Voskuhl, M.D., the lead investigator of the Phase II clinical trial evaluating the Company's oral estriol product candidate, Trimesta(TM), for the treatment of relapsing-remitting multiple sclerosis (MS), will present topline results at the American...

2014-01-15 08:29:07

WESTMINSTER, Colo., Jan. 15, 2014 /PRNewswire/ -- The Rocky Mountain Multiple Sclerosis Center announced today it has named Gina Berg as its new CEO. The Rocky Mountain MS Center is the regional leader in providing clinical care, research, education and support to people with multiple sclerosis (MS) and their families. As CEO, Berg has oversight of the strategic direction and operation of the MS Center's programs and services. She has already assumed her duties. (Photo:...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'